THERAPEUTIC COMPOSITIONS FOR TREATING PANCREATIC CANCER
The present invention is directed to therapeutic compositions for treating pancreatic cancer comprising a cyclohexnone compound and one or more anti-cancer agents. The disclosure includes composition for use in treating pancreatic cancer comprising a compound having the structure: or a pharmaceutica...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
14.05.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention is directed to therapeutic compositions for treating pancreatic cancer comprising a cyclohexnone compound and one or more anti-cancer agents. The disclosure includes composition for use in treating pancreatic cancer comprising a compound having the structure: or a pharmaceutically acceptable salt thereof, and one or more anti-cancer agents, wherein the one or more anti-cancer agents is erlotinib, 5-Fluorouracil, oxaliplatin, irinotecan, gemcitabine, paclitaxel, or a combination thereof.
La présente invention concerne des compositions thérapeutiques pour le traitement du cancer du pancréas comprenant un composé de cyclohexanone et un ou plusieurs agents anticancéreux. La divulgation concerne une composition à utiliser dans le traitement du cancer du pancréas, qui comprend un composé de structure : ou un sel connexe acceptable sur le plan pharmaceutique et un ou plusieurs agents anticancéreux, qui sont lun ou plusieurs des éléments parmi lerlotinib, le 5-fluorouracile, loxaliplatine, lirinotécan, la gemcitabine, le paclitaxel ou une combinaison connexe. |
---|---|
Bibliography: | Application Number: CA20183020933 |